维普中文期刊产品整合服务
17篇 您的检索式:作者名="Grau JJ"
    题名 作者 年代 出处 被引量
1Induction chemotherapy with cisplatin/docetaxel versus cisplatin/5-fluorouracil for locally advanced squamous cell carcinoma of the head and neck:a randomised phase II study显示文摘Fonseca E Grau JJ Sastre J 2005Eur J Cancer2005,41,9:1
2Dihydropyrim - Idine de- hydrogenases and cytidine - deaminase gene polymor - phisms as outcome predictors in resected gastric cancer pa - tients trea- ted with fluoropyrimidine adjuvant chemotherapy显示文摘Grau JJ Caballero M Monz? M 2008J' Surg On- col2008,98,2:1
3Serum vascular endothelial growth factor as a predictive factor in metronomic(weekly) Pacli- taxel treatment for advanced head and neck cancer显示文摘Caballero M Grau JJ Blanch JL 2007Arch Oto- laryngol Head Neck Surg2007,133,11:1
4Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy 显示文摘Grau JJ Caballero M Monzo M 2008J Surg Oncol2008,98,2:1
5Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients 显示文摘Grau JJ Caballero M Verger E 2009Acta Otolaryngol2009,129,11:1
6Outcome of patients treated with palliative weekly Paclitaxel plus Cetuximab in recurrent head and neck cancer after failure of platinum-based therapy显示文摘Sosa AE Grau JJ Feliz L 2014Eur Arc Otorhinolaryngo[2014,271,2:1
7A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy ahme as treatment of unresectable head and neck cancer 显示文摘Hitt R Grau JJ L 6 pez-Pousa A 2014Ann Oncol2014,25,1:1
8Serum vascular endothe-lial growth factor as a predictive factor in metronomic ( weekly)Paclitaxel treatment for advanced head and neck cancer显示文摘Caballero M Grau JJ Blanch JL 2007ArchOtolaryngol Head Neck Surg2007,133,11:1
9A single-arm phase II trial to evaluate the combination of cetuximab plus docetaxel,cisplatin and 5-fluorouracil (TPF) as induction chemotherapy in patients with unresectable SCCHN显示文摘Mesia R Vazquez S Grau JJ 2009J Clin Oncol2009,27,5:1
10Serum vascular endothelial growth factor as a p redictive factor in metronomic(weekly)Paclitaxel treatment for advanced head and neck cancer显示文摘Caballero M Grau JJ Blanch JL 2007Arch Otolaryngol Head Neck Surg2007,133,11:1
11Final results of a ran domized phase Ⅲ trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) versus CRT alone as first-line treatment of unresectable locally advanced head and neck cancer (LAHNC)显示文摘Hitt R Grau JJ Lopez-Pousa A 2009J Clin Oncol2009,,:1
12Dihydropyrimidine dehydrogenases and cytidine-deaminase gene polymorphisms as outcome predictors in resecled gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy 显示文摘Grau JJ Caballero M Monzo M 2008J Surg Oncol2008,8,2:1
13VH gene family utilization of anti-AChR antibodies in experimental autoimmune myasthenia gravis显示文摘Graus YM Verschuuren JJ Bos NA 1993J Neuroimmunol1993,43,:1
14Thymidylate synthase expression in the primary tumor predicts favorable clinical outcome in resected gastric cancer patients treated with adjuvant tegafur显示文摘Grau JJ Domingo- Domenech J Morente V 2004Oncology2004,66,3:1
15Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer显示文摘Caballero M Grau JJ Blanch JL 2007Arch Otolaryngol Head Neck Surg2007,133,11:1
16Dihydropyrimidine dehydrogenases and cytidine deaminase gene polymorphisms as outcome predictors in resected gastric cancer patients treated with fluoropyrimidine adjuvant chemotherapy显示文摘Grau JJ Caballero M Monzo M 2008J Surg Oncol2008,98,2:1
17Serum vascular endothelial growth factor as a predictive factor in metro- nomic (weekly) Paclitaxel treatment for advanced head and neck cancer显示文摘Caballero M Grau JJ Blanch JL 2007Arch Otolaryngol Head Neck Surg2007,133,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费